Oxy133-BTA conjugated analogs (MAX)

N/A

Report date: 2025/01/26 15:41:01
NME

Base Information

Drug NameOxy133-BTA conjugated analogs (MAX)
Drug Alias Nameoxysterol LXR agonist (MAX)OXY-149
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLiver X receptor agonists
TargetsLiver X receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMAX BioPharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesMAX BioPharma Inc
Inactive CompaniesN/A
Active IndicationsOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A